Discover the latest news from Etap-LAB

Contact an expert

Published on the 24 May 2019

Clinical evidence confirms Pep2Dia effects on postprandial glycemia in prediabetic subjects

ETAP-Lab had an instrumental position in Ingredia's projects and successfully predicted in mice the efficacy of Pep2Dia, a new bioactive ingredient expected to reduce postprandial blood sugar levels….

Science and innovation
Published on the 17 May 2019

Syncrosome at the next NeuroFrance Congress in Marseille

SYNCROSOME your dedicated partner for In Vivo Efficacy Studies has been accepted for a poster presentation at NeuroFrance 2019 (Marseille, France, 22-24 May) which is an International Meeting from Soc…

Science and innovation Events
Published on the 15 May 2019

About the future of translational stroke research

Giving new life to old music: about the future of translational stroke research Oral presentation by Pr. Denis Vivien during the 2nd Strok@lliance annual meeting, June 5th 2018, at the Maison de …

Science and innovation
Published on the 17 April 2019

Microbiome & Probiotics Series

See you soon in Rotterdam (20-22 May, 2019) to exchange on Gastrointestinal, Cardiovascular and Central Nervous System diseases.Let's stay tuned and we will give you more details on our talk, booth an…

Science and innovation
Published on the 15 March 2019

ETAP-Cell: New in vitro services in Neurology

ETAP-Lab launches a new in vitro pharmacology activity in the field of proteopathic neurodegenerative diseases ETAP-Lab proudly announces the launch of ETAP-Cell: a new in vitro pharmacology activ…

Science and innovation
Published on the 11 March 2019

STROK@lliance – Expert Opinion #1

Ischemia-reperfusion injury: Recent clinical data challenge the translational value of mechanical MCAO models of stroke in rodents Ischemia-reperfusion injury has been hypothesized to play a major…

Science and innovation
Published on the 21 January 2019

Syncrosome & the Translational Neuroscience Congress

As you know Syncrosome is a preclinical CRO managing efficacy in vivo/ in vitro studies with more than 15 disease models validated in house and highly reproducible. Syncrosome is involved in Central …

Events
Published on the 16 January 2019

Annual Report of 2018

2018 has been a rewarding year for Strok@lliance as a result of several projects completed and new models that have been developed! Here is a brief summary of the key points regarding our develop…

Company

Explore our scientific resources and browse posters…

Explore our resources